← Eichor
Condition: Cicatricial Alopecia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Cicatricial Alopecia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Lichen Planopilaris in Routine Clinical
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT06512753
Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
Phase 4 · 1 location(s) · Wake Forest University Health Sciences · NCT04207931
Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07487948
1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
NA · 1 location(s) · Montefiore Medical Center · NCT05460611
A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia
NA · 1 location(s) · Wake Forest University Health Sciences · NCT04764331
Deucravacitinib in the Treatment of Cicatricial Alopecias
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07508488
Non-Ablative Laser to Treat Scarring Alopecia With Hair Follicle Gene Expression Analysis
NA · 1 location(s) · Montefiore Medical Center · NCT06946550
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.